Literature DB >> 11781766

Cost-effectiveness of group and mixed family-based treatment for childhood obesity.

G S Goldfield1, L H Epstein, C K Kilanowski, R A Paluch, B Kogut-Bossler.   

Abstract

OBJECTIVE: Family-based, behavioral treatment has been shown to be an effective intervention for the management of pediatric obesity. The goal of this study was to compare the cost-effectiveness of two protocols for the delivery of family-based behavioral treatment. RESEARCH METHODS AND PROCEDURES: Thirty-one families with obese children were randomized to groups in which families were provided mixed treatment incorporating both group and individualized treatment vs group treatment only. Cost-effectiveness of treatment was defined as the magnitude of reduction in standardized BMI and percentage overweight per dollar spent for recruitment and treatment. Anthropometric data were assessed at baseline, 6 months and 12 months post-randomization.
RESULTS: Results for the 24 families with complete data showed the group intervention was significantly more cost-effective than the mixed treatment. This was due to the similarity between the two groups in Z-BMI or percentage overweight change for children and their parents, while the mixed treatment was significantly more expensive to deliver than the group treatment. DISCUSSION: These findings suggest that a family-based, behavioral intervention employing group treatment alone is a more cost-effective approach to treating pediatric obesity than a mixed group plus individual format.

Entities:  

Mesh:

Year:  2001        PMID: 11781766     DOI: 10.1038/sj.ijo.0801838

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  44 in total

1.  Case study: Behavior changes in the family-focused obesity prevention HOME Plus program.

Authors:  Michelle L Myers; Jayne A Fulkerson; Sarah E Friend; Melissa L Horning; Colleen F Flattum
Journal:  Public Health Nurs       Date:  2018-04-06       Impact factor: 1.462

Review 2.  Behavioral intervention in the treatment of obesity in children and adolescents: implications for Mexico.

Authors:  Elissa Jelalian; E Whitney Evans
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

3.  Comparison of program costs for parent-only and family-based interventions for pediatric obesity in medically underserved rural settings.

Authors:  David M Janicke; Bethany J Sallinen; Michael G Perri; Lesley D Lutes; Janet H Silverstein; Babette Brumback
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

4.  Recent Updates on the Efficacy of Group Based Treatments for Pediatric Obesity.

Authors:  Jacqueline F Hayes; Myra Altman; Jackson H Coppock; Denise E Wilfley; Andrea B Goldschmidt
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-04

5.  Family involvement in the treatment of childhood obesity: the Copenhagen approach.

Authors:  H N Grønbaek; S A Madsen; K F Michaelsen
Journal:  Eur J Pediatr       Date:  2009-02-21       Impact factor: 3.183

Review 6.  Nonalcoholic steatohepatitis in children.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

7.  An adaptation of family-based behavioral pediatric obesity treatment for a primary care setting: group health family wellness program pilot.

Authors:  Karin R Riggs; Paula Lozano; Amy Mohelnitzky; Sarah Rudnick; Julie Richards
Journal:  Perm J       Date:  2014-06-09

Review 8.  The prevention and treatment of childhood obesity.

Authors:  P Wilson; S O'Meara; C Summerbell; S Kelly
Journal:  Qual Saf Health Care       Date:  2003-02

Review 9.  Outcome measurement in economic evaluations of public health interventions: a role for the capability approach?

Authors:  Paula K Lorgelly; Kenny D Lawson; Elisabeth A L Fenwick; Andrew H Briggs
Journal:  Int J Environ Res Public Health       Date:  2010-05-06       Impact factor: 3.390

Review 10.  Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Authors:  Sanjib Saha; Ulf-G Gerdtham; Pia Johansson
Journal:  Int J Environ Res Public Health       Date:  2010-08-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.